Loading...

Bridget Keenan, MD, PhD

Title(s)Clinical Fellow, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
Phone415-885-7276
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns Hopkins University School of Medicine, Baltimore, MDMD-PhD05/2015Immunology
    University of California San Francisco, San Francisco, CA06/2017Internal Medicine
    University of California San Francisco, San Francisco, CAHematology/Oncology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The "Third Shift": A Path Forward to Recognizing and Funding Gender Equity Efforts. J Womens Health (Larchmt). 2020 Jul 31. Santhosh L, Keenan BP, Jain S. PMID: 32744885.
      View in: PubMed   Mentions:    Fields:    
    2. Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development. Cancer Prev Res (Phila). 2020 Jul; 13(7):569-582. Chu NJ, Anders RA, Fertig EJ, Cao M, Hopkins AC, Keenan BP, Popovic A, Armstrong TD, Jaffee EM, Zimmerman JW. PMID: 32409593.
      View in: PubMed   Mentions:    Fields:    
    3. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer. 2019 10 18; 7(1):267. Keenan BP, Fong L, Kelley RK. PMID: 31627733.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    4. Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer. 2019 Dec 15; 125(24):4426-4434. Lowery MA, Goff LW, Keenan BP, Jordan E, Wang R, Bocobo AG, Chou JF, O'Reilly EM, Harding JJ, Kemeny N, Capanu M, Griffin AC, McGuire J, Venook AP, Abou-Alfa GK, Kelley RK. PMID: 31454426.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241. Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. PMID: 31154669.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. The Complex Problem of Women Trainees in Academic Medicine. J Hosp Med. 2019 03; 14(3):186-188. Keenan B, Santhosh L, Thompson V, Harleman E. PMID: 30811328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO). Journal of Clinical Oncology. 2019 Feb 1; 37(4_suppl):tps464-tps464. Bridget Keenan, Madeline J Griffith, Kelly Bauer, Paige M. Bracci, Spencer Behr, Sarah E Umetsu, John Dozier Gordan, Zoe Ngo, Syma Iqbal, Diana L. Hanna, Alan P. Venook, Anthony B. El-Khoueiry, Lawrence Fong, Robin Kate Kelley. .
      View in: Publisher Site   Mentions:
    8. Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses. Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):4087-4087. Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Sarah E Umetsu, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong. .
      View in: Publisher Site   Mentions:
    9. Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC). Journal of Clinical Oncology. 2018 Feb 1; 36(4_suppl):386-386. Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Alexander Cheung, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong. .
      View in: Publisher Site   Mentions:
    10. True, True, Related? Autoimmune Polyglandular Syndrome Type II. Am J Med. 2016 Jan; 129(1):38-41. Keenan BP, Yalamanchi S, Hsu S, Norsworthy K, Brown TT. PMID: 26450169.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology. 2014 Jun; 146(7):1784-94.e6. Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG, Dubensky TW, Hassan R, Armstrong TD, Jaffee EM. PMID: 24607504.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    12. Tumor immunology: multidisciplinary science driving basic and clinical advances. Cancer Immunol Res. 2013 Jul; 1(1):16-23. Keenan BP, Jaffee EM, Armstrong TD. PMID: 24409447.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    13. Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance. Ann N Y Acad Sci. 2013 May; 1284:12-6. Keenan B, Jaffee EM. PMID: 23651188.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    14. Whole cell vaccines--past progress and future strategies. Semin Oncol. 2012 Jun; 39(3):276-86. Keenan BP, Jaffee EM. PMID: 22595050.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    15. Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme. Arch Dermatol. 2010 May; 146(5):577. Keenan BP, Abuav R. PMID: 20479324.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutat Res. 2010 Jan 05; 683(1-2):115-22. Cheng Y, Zhang Z, Keenan B, Roschke AV, Nakahara K, Aplan PD. PMID: 19909760.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    17. A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kinetics. J Biol Chem. 2005 Jun 10; 280(23):22406-17. Fialcowitz EJ, Brewer BY, Keenan BP, Wilson GM. PMID: 15809297.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    Bridget's Networks
    Concepts (134)
    Derived automatically from this person's publications.
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _